Fluzone Trivalent Northern Hemisphere

INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) · Injection, Suspension · Intramuscular

Prescription (Rx)

No FDA structured label text is available for Fluzone Trivalent Northern Hemisphere. The NDC listings below come from the FDA National Drug Code directory.

Active ingredients

Fluzone Trivalent Northern Hemisphere NDC products (3)

NDCStrength & formLabelerType
83703-087Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL; Influenza A Virus…
Injection, Suspension
Bamboo US BidCo LLCBLA
49281-426Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mg; Influenza A…
Injection, Suspension
Sanofi Vaccines US Inc.BLA
49281-645Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL; Influenza A…
Injection, Suspension
Sanofi Vaccines US Inc.BLA

Frequently asked questions

Who makes Fluzone Trivalent Northern Hemisphere?

Fluzone Trivalent Northern Hemisphere is listed by 2 labelers in the FDA NDC directory, including Bamboo US BidCo LLC, Sanofi Vaccines US Inc..